The London-based artificial intelligence note-taking startup secured backing from Nat Friedman and Daniel Gross.
"Since our launch a year ago, people have started referring to Granola as their ‘second brain’. With Granola 2.0, we’re bringing that power to your entire team, tapping into the most up-to-date, relevant data on what’s happening in your company, the conversations your employees are having day in, day out"
Brighton Park Capital led the Series B round, with participation from Ankona Capital and Hyperlink Ventures, to fund autonomous maritime technology development.
"At Orca AI, we are constantly pushing the boundaries of what is possible when AI supports human decision-making at sea."
Accel led the Series B round to support platform development and go-to-market expansion.
"GenAI has pushed the boundaries of what’s possible with design, but for creative professionals working at the break-neck speed of today, velocity means little without quality and control. Recraft was built with one core idea: AI should amplify creativity, not compromise it. With this funding, we’re doubling down on our commitment to creative teams, providing the tools they need to stay on-brand and scale quickly."
Avery Dennison has backed Addionics in a Series B round to support manufacturing scale and commercialisation.
"We are creating a mutually beneficial partnership. The investment will enable Addionics to accelerate the development and commercialization of its unique technology for current collectors. Our process know-how, materials science knowledge and global reach complement Addionics’ novel technology and entrepreneurial spirit. Equally important, the partnership contributes to advancing sustainability."
— Pankaj Bhardwaj, Vice president and general manager, Avery Dennison Materials Group, Asia, Middle East & Africa
The Series B round was led by Intrepid Growth Partners and will support international expansion and product development.
"At Intrepid Growth Partners, we invest in transformative machine intelligence-driven solutions that address critical challenges, and Skin Analytics exemplifies this vision. Their technology is redefining early skin cancer detection, improving patient outcomes while reducing healthcare costs. We are excited to support their growth as they scale their impact globally."